Human Rights, Minimum Standards and Monitoring at the European and International Levels
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Practical Guidance for collaborative interventions 
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                3rd Edition – July 2017
www.msfaccess.org
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...to those for adolescents and children. This alignment is expected to simplify procurement, promote access to treatment among children in low- and middle-income countries and contribute to global efforts to eliminate the disease
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Mapping Report - Catalonia (Spain).
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Mapping Report - Portugal
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Mapping Report - Ireland.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
  ...  direct-acting antiviral (DAA) treatment of adolescents and children ages ≥3 years of age
    simplified HCV service delivery (decentralization, integration and task sharing)
    HCV diagnostics – use of point-of-care (POC) HCV ribonucleic acid (RNA) assays and reflex HCV RNA testing. 
These guidelines also update existing chapters without new recommendations, such as the inclusion of new manufacturers’ protocols on the use of dried blood spot (DBS) for HCV RNA testing and new data to inform the limit of detection for HCV RNA assays as a test of cure, in addition to their use for diagnosis.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV
Accessed: 26.09.2019
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...ve the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...sk-sharing, in addition to the use of point-of-care (POC) HCV viral load assays and reflex viral load testing.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations  of  DAAs  can  cure  infection  with  HCV  in  12  weeks,  are  highly  effective  and 
have  limited  side-effects.  Affordability  of  DAAs  has  improved  significantly,  but  access  remains  lim-
i...ted.  Initially,  due  to  their  high  prices,  affordability  of  DAAs  was  limited  in  high-,  middle-  and  low-
income countries alike. Now there is a divide between those countries where, because of intellectual 
property barriers, prices have remained (very) high and other countries where generics are, or can be, 
available at much lower prices. The result is a dual market
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...otype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...rmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
                                                                    more